Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor

NCT06310915 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage IIIB/IV

Interventions

DRUG: Navelbine oral,Pembrolizumab

Sponsor

Guangzhou Institute of Respiratory Disease